Pharmacology & ToxicologybioRxivPreprint
Controlled delivery of iNOS antagonist, 1400W, for synergistic breast cancer therapy
Houman Alimoradi, Marjan Abri Aghdam, Anita Barzegar‐Fallah, Christine Delporte
This study develops pH-responsive nanoparticles to deliver 1400W, an iNOS inhibitor, which synergizes with paclitaxel to enhance anti-tumor effects in TNBC cells.
1 citation